4//SEC Filing
Gordon Gary B. 4
Accession 0000899243-21-002906
CIK 0001797336other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 4:05 PM ET
Size
8.8 KB
Accession
0000899243-21-002906
Insider Transaction Report
Form 4
Gordon Gary B.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-20$5.16/sh+3,000$15,480→ 11,520 total - Exercise/Conversion
Stock Option
2021-01-20−3,000→ 92,000 totalExercise: $5.16Exp: 2029-09-19→ Common Stock (3,000 underlying) - Sale
Common Stock
2021-01-20$15.03/sh−3,000$45,084→ 8,520 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]This option vested and became exercisable as to 25% of the underlying shares of common stock on August 1, 2020 and will become vested and exercisable as to the remainder of the shares in 12 equal quarterly installments thereafter.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001797336
Entity typeother
Related Parties
1- filerCIK 0001811354
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 4:05 PM ET
- Size
- 8.8 KB